SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Lucy Gilbert, Olga Basso, John Sampalis, Igor Karp, Claudia Martins, Jing Feng, Sabrina Piedimonte, Louise Quintal, Agnihotram V Ramanakumar, Janet Takefman, Maria S Grigorie, Giovanni Artho, Srinivasan Krishnamurthy, Assessment of symptomatic women for early diagnosis of ovarian cancer: results from the prospective DOvE pilot project, The Lancet Oncology, 2012, 13, 3, 285

    CrossRef

  2. 2
    Barbara A. Goff, Ovarian Cancer, Obstetrics and Gynecology Clinics of North America, 2012, 39, 2, 183

    CrossRef

  3. 3
    A. W. W. Lim, D. Mesher, A. Gentry-Maharaj, N. Balogun, I. Jacobs, U. Menon, P. Sasieni, Predictive Value of Symptoms for Ovarian Cancer: Comparison of Symptoms Reported by Questionnaire, Interview, and General Practitioner Notes, JNCI Journal of the National Cancer Institute, 2012, 104, 2, 114

    CrossRef

  4. 4
    Barbara A. Goff, Kimberly A. Lowe, Jeannette C. Kane, Marissa D. Robertson, Marcia A. Gaul, M. Robyn Andersen, Symptom triggered screening for ovarian cancer: A pilot study of feasibility and acceptability, Gynecologic Oncology, 2012, 124, 2, 230

    CrossRef

  5. 5
    Joanna Guenther, Anne Stiles, Jane Dimmitt Champion, The lived experience of ovarian cancer: A phenomenological approach, Journal of the American Academy of Nurse Practitioners, 2012, 24, 5
  6. 6
    Sun Hee Rim, Lindsey Polonec, Sherri L. Stewart, Cynthia A. Gelb, A National Initiative for Women and Healthcare Providers: CDC'sInside Knowledge: Get the Facts About Gynecologic Cancer Campaign, Journal of Women's Health, 2011, 20, 11, 1579

    CrossRef

  7. You have free access to this content7
    Robert A. Smith, Vilma Cokkinides, Durado Brooks, Debbie Saslow, Mona Shah, Otis W. Brawley, Cancer screening in the United States, 2011, CA: A Cancer Journal for Clinicians, 2011, 61, 1
  8. 8
    Marian K. PITTS, Wendy HEYWOOD, Richard RYALL, Anthony M. SMITH, Julia M. SHELLEY, Juliet RICHTERS, Judy M. SIMPSON, High prevalence of symptoms associated with ovarian cancer among Australian women, Australian and New Zealand Journal of Obstetrics and Gynaecology, 2011, 51, 1
  9. 9
    Barbara A. Goff, Barbara Matthews, C. Holly A. Andrilla, Jacqueline W. Miller, Katrina F. Trivers, Donna Berry, Denise M. Lishner, Laura-Mae Baldwin, How are symptoms of ovarian cancer managed?, Cancer, 2011, 117, 19
  10. 10
    Rachel Ware Miller, John R van Nagell, Preoperative evaluation of adnexal masses, Women's Health, 2011, 7, 1, 37

    CrossRef

  11. 11
    Sandra Cesario, Advances in the Early Detection of Ovarian Cancer, Nursing for Women's Health, 2010, 14, 3
  12. 12
    Sean M. Devlin, Paula H. Diehr, M. Robyn Andersen, Barbara A. Goff, Patrick T. Tyree, William E. Lafferty, Identification of Ovarian Cancer Symptoms in Health Insurance Claims Data, Journal of Women's Health, 2010, 19, 3, 381

    CrossRef

  13. 13
    Alison M. Karst, Ronny Drapkin, Ovarian Cancer Pathogenesis: A Model in Evolution, Journal of Oncology, 2010, 2010, 1

    CrossRef

  14. 14
    I. Cass, B. Y. Karlan, Ovarian Cancer Symptoms Speak Out--But What Are They Really Saying?, JNCI Journal of the National Cancer Institute, 2010, 102, 4, 211

    CrossRef

  15. 15
    Keng Shen, Beihua Kong, Yunong Gao, Lingying Wu, Ziting Li, Yile Chen, Mengda Li, Yongliang Gao, Ding Ma, Zhilan Peng, Pegylated liposomal doxorubicin as a single agent or as combination therapy with carboplatin in patients with recurrent or refractory epithelial ovarian cancer, Clinical Oncology and Cancer Research, 2010, 6, 6, 387

    CrossRef

  16. 16
    John M. McDonald, Stacey Doran, Christopher P. DeSimone, Fred R. Ueland, Paul D. DePriest, Rachel A. Ware, Brook A. Saunders, Edward J. Pavlik, Scott Goodrich, Richard J. Kryscio, John R. van Nagell, Predicting Risk of Malignancy in Adnexal Masses, Obstetrics & Gynecology, 2010, 115, 4, 687

    CrossRef

  17. 17
    M. A. Rossing, K. G. Wicklund, K. L. Cushing-Haugen, N. S. Weiss, Predictive Value of Symptoms for Early Detection of Ovarian Cancer, JNCI Journal of the National Cancer Institute, 2010, 102, 4, 222

    CrossRef

  18. 18
    M. Montopoli, E. Ragazzi, G. Froldi, L. Caparrotta, Cell-cycle inhibition and apoptosis induced by curcumin and cisplatin or oxaliplatin in human ovarian carcinoma cells, Cell Proliferation, 2009, 42, 2
  19. 19
    Galina Lurie, Pamela J. Thompson, Katharine E. McDuffie, Michael E. Carney, Marc T. Goodman, Prediagnostic symptoms of ovarian carcinoma: A case-control study, Gynecologic Oncology, 2009, 114, 2, 231

    CrossRef

  20. 20
    Lauren M. Walker, John W. Robinson, Qualitative Exploration of Healthcare Relationships Following Delayed Diagnosis of Ovarian Cancer and Subsequent Participation in Supportive-Expressive Group Therapy, Oncology Nursing Forum, 2009, 36, 6, E310

    CrossRef

  21. 21
    Victoria Jayde, Kathryn White, Penny Blomfield, Symptoms and diagnostic delay in ovarian cancer: A summary of the literature, Contemporary Nurse, 2009, 34, 1, 55

    CrossRef

  22. 22
    Ilana Cass, The search for meaning—Symptoms and transvaginal sonography screening for ovarian cancer, Cancer, 2009, 115, 16
  23. 23
    Peter A. Kavsak, Agnes Lee, Hal Hirte, Ed Young, Jack Gauldie, Cytokine elevations in acute coronary syndrome and ovarian cancer: A mechanism for the up-regulation of the acute phase proteins in these different disease etiologies, Clinical Biochemistry, 2008, 41, 7-8, 607

    CrossRef

  24. 24
    Partha M Das, Robert C Bast Jr, Early detection of ovarian cancer, Biomarkers in Medicine, 2008, 2, 3, 291

    CrossRef

  25. 25
    CR Bankhead, C Collins, H Stokes-Lampard, P Rose, S Wilson, A Clements, D Mant, ST Kehoe, J Austoker, Identifying symptoms of ovarian cancer: a qualitative and quantitative study, BJOG: An International Journal of Obstetrics & Gynaecology, 2008, 115, 8
  26. 26
    Joseph Menczer, Angela Chetrit, Siegal Sadetzki, The effect of symptom duration in epithelial ovarian cancer on prognostic factors, Archives of Gynecology and Obstetrics, 2008, 279, 6, 797

    CrossRef

  27. 27
    Maurizio Chiriva-Internati, Fabio Grizzi, Jon A.Weidanz, Raffaele Ferrari, Yu Yuefei, Beatriz Velez, Michael H. Shearer, Devin B. Lowe, Eldo E. Frezza, Everardo Cobos, W. Martin Kast, Ronald C. Kennedy, A NOD/SCID tumor model for human ovarian cancer that allows tracking of tumor progression through the biomarker Sp17, Journal of Immunological Methods, 2007, 321, 1-2, 86

    CrossRef

  28. 28
    Barbara A. Goff, Lynn S. Mandel, Charles W. Drescher, Nicole Urban, Shirley Gough, Kristi M. Schurman, Joshua Patras, Barry S. Mahony, M. Robyn Andersen, Development of an ovarian cancer symptom index, Cancer, 2007, 109, 2
  29. 29
    Iris Simon, Yan Liu, Kirstin L. Krall, Nicole Urban, Robert L. Wolfert, Nam W. Kim, Martin W. McIntosh, Evaluation of the novel serum markers B7-H4, Spondin 2, and DcR3 for diagnosis and early detection of ovarian cancer, Gynecologic Oncology, 2007, 106, 1, 112

    CrossRef

  30. 30
    BD Rufford, IJ Jacobs, U Menon, Feasibility of screening for ovarian cancer using symptoms as selection criteria, BJOG: An International Journal of Obstetrics & Gynaecology, 2007, 114, 1
  31. 31
    A Blythe Ryerson, Christie Eheman, Joseph Burton, Nancy McCall, Don Blackman, Sujha Subramanian, Lisa C. Richardson, Symptoms, Diagnoses, and Time to Key Diagnostic Procedures Among Older U.S. Women With Ovarian Cancer, Obstetrics & Gynecology, 2007, 109, 5, 1053

    CrossRef

  32. 32
    Michelle L. Wynn, Stella Chang, Lucy A. Peipins, Temporal Patterns of Conditions and Symptoms Potentially Associated with Ovarian Cancer, Journal of Women's Health, 2007, 16, 7, 971

    CrossRef

  33. 33
    Christie R. Eheman, Lucy Peipins, Michelle Wynn, Blythe Ryerson, Sherri L. Stewart, Steven S. Coughlin, Nikki A. Hawkins, Mona Saraiya, Development of a Public Health Research Program for Ovarian Cancer, Journal of Women's Health, 2006, 15, 4, 339

    CrossRef

  34. 34
    Lloyd H Smith, Early clinical detection of ovarian cancer: a review of the evidence, Expert Review of Anticancer Therapy, 2006, 6, 7, 1045

    CrossRef

  35. 35
    Ann Schmidt Luggen, GNP Care Guidelines: Update on Ovarian Cancer, Geriatric Nursing, 2006, 27, 2, 93

    CrossRef

  36. 36
    J. V. Lacey, L. A. Brinton, M. F. Leitzmann, T. Mouw, A. Hollenbeck, A. Schatzkin, P. Hartge, Menopausal Hormone Therapy and Ovarian Cancer Risk in the National Institutes of Health-AARP Diet and Health Study Cohort, JNCI Journal of the National Cancer Institute, 2006, 98, 19, 1397

    CrossRef

  37. 37
    Khadra Galaal, Raj Naik, Robert E Bristow, Amit Patel, Andrew Bryant, Heather O Dickinson, Cytoreductive surgery plus chemotherapy versus chemotherapy alone for recurrent epithelial ovarian cancer, The Cochrane Library,
  38. 38
    Khadra Galaal, Raj Naik, Robert E Bristow, Amit Patel, Andrew Bryant, Surgical cytoreduction for recurrent epithelial ovarian cancer, The Cochrane Library,
  39. 39
    Thuria Al Rawahi, Khadra Galaal, Raj Naik, Robert E Bristow, Andrew Bryant, Surgical cytoreduction for recurrent epithelial ovarian cancer, The Cochrane Library,
  40. 40
    Khadra Galaal, Raj Naik, Amit Patel, Andrew Bryant, Heather O Dickinson, Surgical debulking for recurrent epithelial ovarian cancer, The Cochrane Library,